| Product Code: ETC7742920 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Monogenetic Disease Therapy Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Monogenetic Disease Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Monogenetic Disease Therapy Market - Industry Life Cycle |
3.4 Japan Monogenetic Disease Therapy Market - Porter's Five Forces |
3.5 Japan Monogenetic Disease Therapy Market Revenues & Volume Share, By Inheritance Pattern, 2021 & 2031F |
3.6 Japan Monogenetic Disease Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 Japan Monogenetic Disease Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Japan Monogenetic Disease Therapy Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Japan Monogenetic Disease Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of monogenetic diseases in Japan |
4.2.2 Technological advancements in genetic testing and personalized medicine |
4.2.3 Growing investments in research and development for monogenetic disease therapies |
4.3 Market Restraints |
4.3.1 High costs associated with developing and accessing monogenetic disease therapies |
4.3.2 Limited awareness and understanding of monogenetic diseases among healthcare professionals and the general population |
4.3.3 Stringent regulatory requirements for approval of gene therapies in Japan |
5 Japan Monogenetic Disease Therapy Market Trends |
6 Japan Monogenetic Disease Therapy Market, By Types |
6.1 Japan Monogenetic Disease Therapy Market, By Inheritance Pattern |
6.1.1 Overview and Analysis |
6.1.2 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Inheritance Pattern, 2021- 2031F |
6.1.3 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Autosomal, 2021- 2031F |
6.1.4 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Chromosomal, 2021- 2031F |
6.2 Japan Monogenetic Disease Therapy Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Pharmacological, 2021- 2031F |
6.2.3 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Surgical, 2021- 2031F |
6.2.4 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Blood Transfusion, 2021- 2031F |
6.2.5 Japan Monogenetic Disease Therapy Market Revenues & Volume, By EBRT, 2021- 2031F |
6.2.6 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Gene Therapies, 2021- 2031F |
6.2.7 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Monogenetic Disease Therapy Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3.3 Japan Monogenetic Disease Therapy Market Revenues & Volume, By SCID, 2021- 2031F |
6.3.4 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Sickle Cell Anemia, 2021- 2031F |
6.3.5 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Phenylketonuria, 2021- 2031F |
6.3.6 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Monogenetic Disease Therapy Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.3 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.5 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.6 Japan Monogenetic Disease Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Monogenetic Disease Therapy Market Import-Export Trade Statistics |
7.1 Japan Monogenetic Disease Therapy Market Export to Major Countries |
7.2 Japan Monogenetic Disease Therapy Market Imports from Major Countries |
8 Japan Monogenetic Disease Therapy Market Key Performance Indicators |
8.1 Number of clinical trials for monogenetic disease therapies conducted in Japan |
8.2 Adoption rate of genetic testing for monogenetic diseases in clinical practice |
8.3 Funding and grants allocated for research and development of monogenetic disease therapies |
9 Japan Monogenetic Disease Therapy Market - Opportunity Assessment |
9.1 Japan Monogenetic Disease Therapy Market Opportunity Assessment, By Inheritance Pattern, 2021 & 2031F |
9.2 Japan Monogenetic Disease Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 Japan Monogenetic Disease Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Japan Monogenetic Disease Therapy Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Japan Monogenetic Disease Therapy Market - Competitive Landscape |
10.1 Japan Monogenetic Disease Therapy Market Revenue Share, By Companies, 2024 |
10.2 Japan Monogenetic Disease Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here